Seres Therapeutics (MCRB) announced new translational biomarker results for exploratory endpoints from its SER-155 Phase 1b ...

Despite apparently denying the charges, Apple has agreed to the $95 million payout – with each victim eligible for $20 each ...

Customers at the four major mobile phone networks have been issued a warning ahead of a huge service change this year, as we ...

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 assessing belrestotug + dostarlimab in 1L NSCLC and 1L HNSCC - ...

If you see someone at run club with a tinfoil hat, don’t be alarmed: some fitness apps are collecting seven times more ...

Surfshark found two of the most popular exercise and personal training apps collect the most data – Strava and Fitbit. While the 15 apps analysed collect an average of 12 different types of data, ...

The biotech will stop developing two drugs and lay off nearly three-quarters of its staff after its lead therapy wasn’t as potent in early testing as the company expected.

The company has roaming agreements with 400+ cellular carriers worldwide, which are accessible from over 200 cruise ships. In those cases, travelers’ devices will automatically connect to the network ...

A new Opinium survey of 2,000 UK adults, which was commissioned by Uswitch.com and conducted on 7th Jan 2025, has claimed ...

Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

AI is driving significant advancements in the telecommunications industry, improving network management, customer service, ...